Skip to main content

Table 3 Clinical and demographic characteristics and risk of Medication-Related Osteonecrosis of the Jaw

From: Oral health, dental treatment, and medication related osteonecrosis of the jaw in multiple myeloma – a longitudinal cohort study

 

Relative risk (95% CI)

Gender (male)

1.75 (0.97–2.53)

ACE-27 score 2–3

2.00 (1.31–2.69)

Decayed teeth

2.23 (1.59–2.87)

Missed teeth

2.87 (1.83–3.91)**

Periodontitis moderate-severe

4.21 (3.57–4.84)***

Apical periodontitis

0.27 (−0.78–1.32)

Removable prosthetics

3.70 (2.82–4.58)*

Dental treatment prior to BP

0.79 (0.10–1.47)

Dental treatment after BP

7.75 (7.14–8.36)***

Monoclonal antibodies treatment

1.57 (0.89–2.25)

3 or more treatment combinations

4.13 (3.45–4.81)**

  1. Associations are expressed as RR with 95% CI. Significance levels are presented as  * = p < 0. 05 ** = p < 0.01 *** = p < 0.001